Total Payments
$525,866
2024 Payments
$72,166
Companies
65
Transactions
1,174
Medicare Patients
22,646
Medicare Billing
$2.2M
Payment Breakdown by Category
Other$361,534 (68.8%)
Consulting$85,582 (16.3%)
Travel$34,947 (6.6%)
Food & Beverage$33,069 (6.3%)
Research$10,645 (2.0%)
Education$90.53 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $326,359 | 155 | 62.1% |
| Consulting Fee | $85,582 | 38 | 16.3% |
| Travel and Lodging | $34,947 | 142 | 6.6% |
| Food and Beverage | $33,069 | 820 | 6.3% |
| Compensation for serving as faculty or as a speaker for a medical education program | $31,375 | 11 | 6.0% |
| Unspecified | $10,645 | 2 | 2.0% |
| Honoraria | $3,800 | 2 | 0.7% |
| Education | $90.53 | 4 | 0.0% |
Payments by Type
General
$515,222
1,172 transactions
Research
$10,645
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $106,135 | 140 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $87,208 | 137 | $0 (2024) |
| Amgen Inc. | $71,078 | 135 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $56,679 | 78 | $0 (2024) |
| ShockWave Medical, Inc | $45,497 | 33 | $0 (2024) |
| Amarin Pharma Inc. | $34,439 | 44 | $0 (2021) |
| Esperion Therapeutics, Inc. | $19,973 | 27 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $18,597 | 26 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $17,395 | 16 | $0 (2019) |
| PORTOLA PHARMACEUTICALS, INC. | $12,652 | 20 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $72,166 | 188 | Medtronic, Inc. ($55,595) |
| 2023 | $66,576 | 157 | Medtronic, Inc. ($32,576) |
| 2022 | $33,671 | 145 | Shockwave Medical, Inc ($11,786) |
| 2021 | $74,035 | 136 | Esperion Therapeutics, Inc. ($16,914) |
| 2020 | $101,773 | 135 | AstraZeneca Pharmaceuticals LP ($65,076) |
| 2019 | $51,546 | 126 | Amarin Pharma Inc. ($26,981) |
| 2018 | $65,368 | 151 | Amgen Inc. ($20,286) |
| 2017 | $60,730 | 136 | Novartis Pharmaceuticals Corporation ($25,572) |
All Payment Transactions
1,174 individual payment records from CMS Open Payments — Page 1 of 47
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Medtronic, Inc. | — | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| 12/17/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Cardiology | ||||||
| 12/16/2024 | Medtronic, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 12/16/2024 | Bard Peripheral Vascular, Inc. | RotarexS 6 F x 135 cm (Device) | Food and Beverage | In-kind items and services | $103.07 | General |
| Category: Vascular/Oncology | ||||||
| 12/11/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: DIABETES | ||||||
| 11/26/2024 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: Transcatheter Valve Systems | ||||||
| 11/22/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/20/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/20/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $3.34 | General |
| Category: Renal Denervation System | ||||||
| 11/19/2024 | Medtronic, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,250.00 | General |
| 11/14/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $195.05 | General |
| Category: Renal Denervation System | ||||||
| 11/14/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $0.67 | General |
| Category: Renal Denervation System | ||||||
| 11/13/2024 | W. L. Gore & Associates, Inc. | GORE CARDIOFORM Septal Occluder (Device) | Food and Beverage | In-kind items and services | $124.53 | General |
| Category: Devices | ||||||
| 11/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: DIABETES | ||||||
| 11/07/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: Cardiology | ||||||
| 11/01/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.90 | General |
| Category: Cardiovascular | ||||||
| 10/29/2024 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $112.30 | General |
| Category: Transcatheter Valve Systems | ||||||
| 10/29/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $8.86 | General |
| Category: Cardiology | ||||||
| 10/28/2024 | Cook Medical LLC | ZILVER PTX (Device) | Food and Beverage | Cash or cash equivalent | $92.26 | General |
| Category: Peripheral Intervention | ||||||
| 10/25/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/22/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/18/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $3.98 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: DIABETES | ||||||
| 10/04/2024 | W. L. Gore & Associates, Inc. | GORE VIABAHN VBX Balloon Expandable Endo (Device) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Devices | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| ILLUMENATE | Philips Electronics North America Corporation | $6,500 | 1 |
| Review Article | Novartis Pharmaceuticals Corporation | $4,145 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 45 | 5,623 | 21,695 | $3.1M | $667,895 |
| 2022 | 40 | 6,035 | 15,834 | $2.8M | $594,136 |
| 2021 | 47 | 5,394 | 6,566 | $3.0M | $469,423 |
| 2020 | 47 | 5,594 | 6,735 | $3.1M | $461,324 |
Total Patients
22,646
Total Services
50,830
Medicare Billing
$2.2M
Procedure Codes
183
All Medicare Procedures & Services
183 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 1,267 | 1,729 | $276,640 | $138,019 | 49.9% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 158 | 3,140 | $307,720 | $89,526 | 29.1% |
| J1306 | Injection, inclisiran, 1 mg | Office | 2023 | 32 | 9,088 | $118,144 | $84,531 | 71.5% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 160 | 1,673 | $204,106 | $56,598 | 27.7% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 152 | 1,459 | $214,473 | $47,046 | 21.9% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 88 | 122 | $451,400 | $43,870 | 9.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 121 | 121 | $169,763 | $29,826 | 17.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 180 | 181 | $200,471 | $21,624 | 10.8% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 118 | 119 | $224,910 | $19,437 | 8.6% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 85 | 340 | $29,580 | $15,394 | 52.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 115 | 115 | $28,290 | $12,373 | 43.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 919 | 1,078 | $97,020 | $10,239 | 10.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 111 | 154 | $21,714 | $8,974 | 41.3% |
| 33361 | Replacement of aortic valve through the skin and femoral artery | Facility | 2023 | 16 | 16 | $125,968 | $8,869 | 7.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 147 | 152 | $16,264 | $8,595 | 52.8% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 117 | 121 | $42,688 | $7,157 | 16.8% |
| 93459 | Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | Facility | 2023 | 40 | 43 | $100,534 | $6,769 | 6.7% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 143 | 143 | $55,484 | $6,224 | 11.2% |
| 37224 | Balloon dilation of artery of leg | Facility | 2023 | 19 | 21 | $64,218 | $5,369 | 8.4% |
| 37221 | Insertion of stent in groin artery, initial vessel | Facility | 2023 | 16 | 16 | $84,672 | $5,216 | 6.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 481 | 526 | $10,520 | $4,380 | 41.6% |
| 75716 | Review by radiologist of both arms or legs arteries image | Facility | 2023 | 49 | 56 | $17,024 | $3,906 | 22.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 36 | 36 | $9,216 | $3,545 | 38.5% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 14 | 14 | $30,856 | $3,156 | 10.2% |
| 92920 | Balloon dilation of single coronary artery or branch | Facility | 2023 | 11 | 11 | $37,642 | $2,839 | 7.5% |
About Dr. Barry Bertolet, MD
Dr. Barry Bertolet, MD is a Cardiovascular Disease healthcare provider based in Tupelo, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1295845444.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Barry Bertolet, MD has received a total of $525,866 in payments from pharmaceutical and medical device companies, with $72,166 received in 2024. These payments were reported across 1,174 transactions from 65 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($326,359).
As a Medicare-enrolled provider, Bertolet has provided services to 22,646 Medicare beneficiaries, totaling 50,830 services with total Medicare billing of $2.2M. Data is available for 4 years (2020–2023), covering 183 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Tupelo, MS
- Active Since 08/30/2006
- Last Updated 08/02/2013
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1295845444
Products in Payments
- FARXIGA (Drug) $86,598
- Repatha (Biological) $69,525
- ENTRESTO (Drug) $45,093
- Vascepa (Drug) $34,439
- SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER (Device) $24,911
- NEXLIZET (Drug) $19,826
- PRALUENT (Drug) $17,395
- Vascular Lithotripsy (Device) $14,982
- BEVYXXA (Drug) $12,624
- PRALUENT ALIROCUMAB INJECTION (Biological) $11,895
- PRALUENT (Biological) $11,822
- LEQVIO (Drug) $11,586
- SYMPLICITY G3 (Device) $7,740
- Stellarex (Device) $6,549
- IN.PACT ADMIRAL (Device) $5,738
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) $5,604
- Ozempic (Drug) $4,875
- INTERVENTIONAL ANGIOGRAPHY SYSTEM (Device) $4,024
- DyeVert (Device) $3,744
- Cardiva VASCADE MVP VVCS 6-12F (Device) $3,500
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Tupelo
James Stone, M.d, M.D
Cardiovascular Disease — Payments: $120,310
Cardiovascular Disease $120,310
Dr. Michael Boler, D.o, D.O
Cardiovascular Disease — Payments: $7,154
Cardiovascular Disease $7,154
Roger Williams, Md, MD
Cardiovascular Disease — Payments: $7,109
Cardiovascular Disease $7,109
Dr. Benjamin Blossom, M.d, M.D
Cardiovascular Disease — Payments: $6,791
Cardiovascular Disease $6,791
Joseph Adams, Md, MD
Cardiovascular Disease — Payments: $4,212
Cardiovascular Disease $4,212
John Estess, Md, MD
Cardiovascular Disease — Payments: $3,887
Cardiovascular Disease $3,887